Effects of anti-IL-5 monoclonal antibody on the murine model of nasal allergy

被引：19
|
作者：
Asakura, K [1 ]
Saito, H [1 ]
Watanabe, M [1 ]
Ogasawara, H [1 ]
Matsui, T [1 ]
Kataura, A [1 ]
机构：
[1] Sapporo Med Univ, Dept Otolaryngol, Chuo Ku, Sapporo, Hokkaido 060, Japan
来源：
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY | 1998年 / 116卷 / 01期
关键词：
nasal allergy; anti-IL-5 monoclonal antibody; murine model;
D O I：
10.1159/000023924
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
IL-5 is known to be closely related to the infiltration, activation and proliferation of eosinophils. In this study, we evaluated the in vivo effects of anti-IL-5 monoclonal antibody (mAb) in the murine model of nasal allergy. The mAb treatment inhibited the antigen-induced late phase eosinophilia, but had no effects on the number of basophilic cells. It also inhibited early phase nasal symptoms, and tended to inhibit histamine hypersensitivity. These findings suggest that IL-5 plays an important role in the pathogenesis of allergic nasal disorders.
引用
收藏
页码：49 / 52
页数：4
相关论文
共 50 条
  • [31] Depletion of eosinophil infiltration by anti-IL-5 monoclonal antibody (TRFK-5) accelerates open skin wound epithelial closure
    Yang, J
    Torio, A
    Donoff, RB
    Gallagher, GT
    Egan, R
    Weller, PF
    Wong, DTW
    AMERICAN JOURNAL OF PATHOLOGY, 1997, 151 (03): : 813 - 819
  • [32] Anti-IL-5 antibody attracts Cephalon to agree option for Ception acquisition
    Nature Reviews Drug Discovery, 2009, 8 : 185 - 185
  • [33] Mepolizumab, a humanized anti-IL-5 mAb, as a treatment option for severe nasal polyposis
    Gevaert, Philippe
    Van Bruaene, Nicholas
    Cattaert, Tom
    Van Steen, Kristel
    Van Zele, Thibaut
    Acke, Frederic
    De Ruyck, Natalie
    Blomme, Katrien
    Sousa, Ana R.
    Marshall, Richard P.
    Bachert, Claus
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 128 (05) : 989 - U428
  • [34] Anti-IL-5 antibody attracts Cephalon to agree option for Ception acquisition
    不详
    NATURE REVIEWS DRUG DISCOVERY, 2009, 8 (03) : 185 - 185
  • [35] Effect of anti-IL-5 antibody on eosinophilopoiesis and airway eosinophilia induced by allergen
    Sitkauskiene, B
    Sjöstrand, M
    Lötvall, J
    ALLERGY, 2002, 57 : 132 - 132
  • [36] A Phase 1 study of the long-acting anti-IL-5 monoclonal antibody GSK3511294 in patients with asthma
    Singh, Dave
    Fuhr, Rainard
    Bird, Nicholas P.
    Mole, Sarah
    Hardes, Kelly
    Man, Yau Lun
    Cahn, Anthony
    Yancey, Steven W.
    Pouliquen, Isabelle J.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 88 (02) : 702 - 712
  • [37] SB 240563, a humanized anti-IL-5 monoclonal antibody. Initial single dose safety and activity in patients with asthma
    Leckie, MJ
    ten Brinke, A
    Lordan, J
    Khan, J
    Diamant, Z
    Walls, CM
    Cowley, H
    Hansel, TT
    Djukanovic, R
    Sterk, PJ
    Holgate, ST
    Barnes, PJ
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A624 - A624
  • [38] Rebound eosinophilia after treatment of hypereosinophilic syndrome and eosinophilic gastroenteritis with monoclonal anti-IL-5 antibody SCH55700
    Kim, YJ
    Prussin, C
    Martin, B
    Law, MA
    Haverty, TP
    Nutman, TB
    Klion, AD
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2004, 114 (06) : 1449 - 1455
  • [39] Intravenous anti-IL-5 monoclonal antibody reduces eosinophils and tenascin deposition in allergen-challenged human atopic skin
    Phipps, S
    Flood-Page, P
    Menzies-Gow, A
    Ong, YE
    Kay, AB
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2004, 122 (06) : 1406 - 1412
  • [40] Nasal Symptoms in Asthmatic Patients under Treatment with Anti-IL-5 Monoclonal Antibodies. A Real-Life Cohort Study
    Maza-Solano, Juan
    Calvo-Henriquez, Christian
    Alobid, Isam
    Alvarez-Cendrero, Marta
    Palomares, Oscar
    Moreno-Luna, Ramon
    Santos-Perez, Jaime
    Gonzalez-Garcia, Jaime
    Sanchez-Gomez, Serafin
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (23)
12345